Press Release: Arcellx : Arcellx CMO Discusses Novel Investigational CAR-T Therapy During Multiple Myeloma Awareness Month
NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Today's Marketplace (TMP) is proud to announce a featured interview with Arcellx, Inc. (NASDAQ: ACLX) Chief Medical Officer...
Read full article »
Arcellx is a Maryland-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases.
Read more